Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis

NCT00751881 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00751881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00751881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
August 31, 2015
Enrollment
1,169 (actual)
Sites
193

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis